5-氨基乙酰丙酸增强高级别胶质瘤手术可视化:前瞻性多中心研究
结果显示术者判断的PPIX荧光对HGG病理诊断敏感性96.5%、阳性预测值95.4%、诊断准确率92.4%,药物相关不良事件发生率22%。
要点
- 术者判断的PPIX荧光对HGG病理诊断敏感性和阳性预测值均较高
- 5-ALA荧光引导手术在受训术者中未增加神经系统并发症
- 术后KPS在48小时和2周下降,6周时恢复至术前水平
核心结论
- 术者判断的PPIX荧光对高级别胶质瘤具有高敏感性和高阳性预测值,5-ALA耐受性良好,受训术者用于HGG荧光引导手术未伴随额外神经系统并发症。
研究设计与样本
- 单臂、多中心、前瞻性研究,纳入18-80岁、KPS>60、MRI诊断疑似新发或复发可切除HGG的成人患者。
- 术后随访6周,记录不良事件、神经系统查体变化和KPS评分,并对KPS下降、EOR和残留强化肿瘤体积行多因素分析。
主要发现
- PPIX荧光对HGG病理诊断的敏感性为96.5%,特异性为29.4%,阳性预测值为95.4%,诊断准确率为92.4%。
- 药物相关不良事件发生率为22%;可能由荧光引导手术导致的术中神经损伤所致严重不良事件发生率为4.3%;2例死亡与荧光引导手术无关。
- 与术前相比,术后KPS在48小时和2周显著降低,术后6周无差异;强化肿瘤完全切除率为51.9%。
- 术前肿瘤体积较小和使用术中MRI可预测更低的残留肿瘤体积。
关键数值与推荐
- PPIX荧光诊断HGG:敏感性96.5%、特异性29.4%、阳性预测值95.4%、诊断准确率92.4%。
- 药物相关不良事件发生率22%,术中神经损伤相关严重不良事件发生率4.3%。
- 强化肿瘤完全切除率51.9%。
临床怎么用
- 对疑似新发或复发可切除HGG的成人患者,可考虑5-ALA荧光引导手术辅助术中肿瘤识别。
- 由受训术者实施5-ALA荧光引导手术,需关注术后早期KPS下降并在6周随访评估恢复情况。
- 术中小肿瘤体积和术中MRI的使用可能有助于降低残留肿瘤体积。
局限性
- 研究为单臂设计,无对照��。
- 特异性较低(29.4%),荧光判断存在假阳性可能。
- 随访时间仅6周,未报告长期生存或EOR与生存关系的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Greater extent of resection (EOR) is associated with longer overall survival in patients with high-grade gliomas (HGGs). 5-Aminolevulinic acid (5-ALA) can increase EOR by improving intraoperative visualization of contrast-enhancing tumor during fluorescence-guided surgery (FGS). When administered orally, 5-ALA is converted by glioma cells into protoporphyrin IX (PPIX), which fluoresces under blue 400-nm light. 5-ALA has been available for use in Europe since 2010, but only recently gained FDA approval as an intraoperative imaging agent for HGG tissue. In this first-ever, to the authors' knowledge, multicenter 5-ALA FGS study conducted in the United States, the primary objectives were the following: 1) assess the diagnostic accuracy of 5-ALA-induced PPIX fluorescence for HGG histopathology across diverse centers and surgeons; and 2) assess the safety profile of 5-ALA FGS, with particular attention to neurological morbidity. METHODS: This single-arm, multicenter, prospective study included adults aged 18-80 years with Karnofsky Performance Status (KPS) score > 60 and an MRI diagnosis of suspected new or recurrent resectable HGG. Intraoperatively, 3-5 samples per tumor were taken and their fluorescence status was recorded by the surgeon. Specimens were submitted for histopathological analysis. Patients were followed for 6 weeks postoperatively for adverse events, changes in the neurological exam, and KPS score. Multivariate analyses were performed of the outcomes of KPS decline, EOR, and residual enhancing tumor volume to identify predictive patient and intraoperative variables. RESULTS: Sixty-nine patients underwent 5-ALA FGS, providing 275 tumor samples for analysis. PPIX fluorescence had a sensitivity of 96.5%, specificity of 29.4%, positive predictive value (PPV) for HGG histopathology of 95.4%, and diagnostic accuracy of 92.4%. Drug-related adverse events occurred at a rate of 22%. Serious adverse events due to intraoperative neurological injury, which may have resulted from FGS, occurred at a rate of 4.3%. There were 2 deaths unrelated to FGS. Compared to preoperative KPS scores, postoperative KPS scores were significantly lower at 48 hours and 2 weeks but were not different at 6 weeks postoperatively. Complete resection of enhancing tumor occurred in 51.9% of patients. Smaller preoperative tumor volume and use of intraoperative MRI predicted lower residual tumor volume. CONCLUSIONS: PPIX fluorescence, as judged by the surgeon, has a high sensitivity and PPV for HGG. 5-ALA was well tolerated in terms of drug-related adverse events, and its application by trained surgeons in FGS for HGGs was not associated with any excess neurological morbidity.
引用
- Schupper AJ, Baron RB, Cheung W, et al. 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study. J Neurosurg. 2021. PMID: 34624862. doi:10.3171/2021.5.JNS21310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。